Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

New treatments for PCOS focus on managing symptoms and improving fertility.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

PCOD mainly affects young women, causing symptoms like irregular periods and weight gain, with mixed success from lifestyle changes and medication.

Targeting androgen receptors in the skin is the most effective treatment for hyperandrogenism-related skin issues.

The document concludes that various skin conditions have specific treatments and that adequate calcium intake may prevent osteoporosis.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.